Infectious Diseases News and Research

RSS

Research roundup: Studying states' readiness for insurance exchanges

Unauthorized immigrants' options for health care generally consist of hospital emergency rooms and community health centers. Using nationally representative survey data from 2000 to 2009, researchers compared medical spending for unauthorized immigrants, legal residents, naturalized citizens, and natives of the United States and found that "unauthorized immigrants have lower health care spending overall but higher rates of receiving uncompensated care than legal immigrants and US natives."

15 Jun 2013

Educating pediatricians on appropriate antibiotic usage can improve outcomes in children’s infections

As disease-causing microbes continue their worrisome trend of developing resistance to commonly used antibiotics, public health experts have called for more selective use of those medicines. A new study suggests that educating pediatricians in their offices, and auditing their prescription patterns, encourages them to choose more appropriate antibiotics for children with common respiratory infections.

14 Jun 2013

Experts raise awareness about the importance of flu vaccine

The last flu season arrived four weeks early, was more intense than expected and resulted in the deaths of more than 110 children in the United States. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Center are raising awareness about the importance of the flu vaccine, which remains the best option to reduce a person's risk of contracting the virus. The flu season can start as early as late September and usually runs for about 12 to 15 weeks.

14 Jun 2013

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Ten scientists were named Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts today. The fellowship provides support to advance grantees' research, enables them to study with prominent U.S. scientists, and invests seed capital to help them establish laboratories in their home countries.

14 Jun 2013

Study provides new insight into how pyrazinamide works

Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.

14 Jun 2013

Microbiologist uses new Geographic Information System to track deadly outbreaks of drug-resistant TB

TORONTO, ON - Professor Frances Jamieson at the University of Toronto's Department of Laboratory Medicine and Pathobiology (LMP), and Medical Microbiologist, Public Health Ontario, is leading the way in tracking potentially deadly outbreaks of tuberculosis (TB) with a powerful new Geographic Information System (GIS) application, known as Ontario Universal Typing - Tuberculosis (OUT-TB) Web.

13 Jun 2013

Investigational all-oral interferon-free combination from Boehringer Ingelheim achieves 95% viral cure rates in genotype-1b hepatitis C patients

New data from Boehringer Ingelheim’s interferon-free SOUND-C3 study were presented during the APASL Liver Week in Singapore. The Phase IIb study investigated the efficacy and safety of faldaprevir+ and deleobuvir+ (BI 207127) plus ribavirin in treatment-naïve patients with genotype-1b (GT-1b) hepatitis C virus (HCV),1 one of the most common types of HCV globally.2

13 Jun 2013

New collaboration to advance cancer immunotherapy research

The Cancer Research Institute, the Ludwig Institute for Cancer Research and Immune Design, a biotech company focused on immune-based therapies for cancer and other human diseases, today announced that they have signed a collaboration agreement to advance cancer immunotherapy research.

13 Jun 2013

NTU develops social media-based system that can predict dengue outbreaks

When it comes to stopping dengue, social media posts, tweets and a web system may be just what the doctor ordered.

12 Jun 2013

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.

12 Jun 2013

Johns Hopkins researchers develop experimental vaccine for TB meningitis

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

12 Jun 2013

Research could lead to new ways to combat chlamydia

A protein secreted by the chlamydia bug has a very unusual structure, according to scientists in the School of Medicine at The University of Texas Health Science Center San Antonio. The discovery of the protein's shape could lead to novel strategies for diagnosing and treating chlamydia, a sexually transmitted disease that infects an estimated 2.8 million people in the U.S. each year.

12 Jun 2013

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

11 Jun 2013

Study finds only 5% of US wash hands long enough to kill germs

A new study by Michigan State University researchers found that only 5 percent of people who used the bathroom washed their hands long enough to kill the germs that can cause infections.

11 Jun 2013

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

10 Jun 2013

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

10 Jun 2013

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1

10 Jun 2013

State highlights: Ore. schools face insurance exchange choice

Wal-Mart Stores Inc. wages are so low they force many of its employees onto the public doles, creating a drag on taxpayers and the economy, according to a new report from the staff of congressional Democrats. The report analyzes data from Wisconsin's Medicaid program, estimating that a single 300-person Wal-Mart Supercenter in that state likely costs taxpayers at least $904,542 per year and could cost up to $1,744,590 per year, or roughly $5,815 per employee (Lazo, 6/7).

10 Jun 2013

Proventix Systems honors physicians for excellence and leadership in hand hygiene

Proventix Systems, Inc. of Birmingham, Ala. today awarded the Lathem Physician Leadership Award in Hand Hygiene to five physicians who demonstrate a commitment to hand hygiene excellence and leadership in their facilities.

7 Jun 2013

ODH hosts symposium on ‘Health Information Exchanges’ for research and public health improvement

Today, the Ohio Department of Health (ODH) and Case Western Reserve University School of Medicine's Weatherhead Institute for Family Medicine and Community Health are hosting the second annual Ohio Health Data Symposium, a meeting for research and public health experts. The collaboration's theme is "Health Information Exchanges: Opportunities for Research and Public Health Improvement."

7 Jun 2013

Infectious Diseases News and Research

Research roundup: Studying states' readiness for insurance exchanges

Educating pediatricians on appropriate antibiotic usage can improve outcomes in children’s infections

Experts raise awareness about the importance of flu vaccine

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Study provides new insight into how pyrazinamide works

Microbiologist uses new Geographic Information System to track deadly outbreaks of drug-resistant TB

Investigational all-oral interferon-free combination from Boehringer Ingelheim achieves 95% viral cure rates in genotype-1b hepatitis C patients

New collaboration to advance cancer immunotherapy research

NTU develops social media-based system that can predict dengue outbreaks

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Research could lead to new ways to combat chlamydia

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Study finds only 5% of US wash hands long enough to kill germs

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

NanoViricides files Orphan Drug application with FDA for DengueCide

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

State highlights: Ore. schools face insurance exchange choice

Proventix Systems honors physicians for excellence and leadership in hand hygiene

ODH hosts symposium on ‘Health Information Exchanges’ for research and public health improvement

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News